Bioorganic & Medicinal Chemistry 2001-10-01

In vitro selection of DNA aptamers that bind L-tyrosinamide.

E Vianini, M Palumbo, B Gatto

Index: Bioorg. Med. Chem. 9(10) , 2543-8, (2001)

Full Text: HTML

Abstract

We have applied SELEX (Systematic Evolution of Ligands by EXponential enrichment), a combinatorial method that employs biopolymers for drug discovery, to identify single stranded DNA sequences able to bind L-Tyrosinamide, a simple mimic of Tyrosine, an amino acid essential to the catalytic activity of several enzymes of pharmaceutical interest. After 15 SELEX cycles using L-Tyrosinamide immobilized on an affinity chromatography column, the percentage of aptamers specifically eluted from the affinity column with free L-Tyrosinamide was 55% of the total. Aptamers were subcloned and sequenced, allowing the identification of a highly conserved consensus sequence, and showed a K(d) value for L-Tyrosinamide of 45 microM. The identified aptamer sequence will constitute the basis for further in vitro evolution protocols and structure-based drug design.


Related Compounds

Related Articles:

Solvent selection and optimization of α-chymotrypsin-catalyzed synthesis of N-Ac-Phe-Tyr-NH2 using mixture design and response surface methodology.

2012-01-01

[Biotechnol. Prog. 28(6) , 1443-9, (2012)]

Enzymatic copolymerization alters the structure of unpolymerized mixtures of the biomimetic monomers: the amphiphilic decyl ester of L-tyrosine and L-tyrosineamide--an AFM investigation of nano- to micrometer-scale structure differences.

2004-01-01

[Biomacromolecules 5(5) , 1869-76, (2004)]

Derivatization and purification of bisecting tyrosinamide-oligosaccharides from ovotransferrin.

1994-12-01

[Arch. Biochem. Biophys. 315(2) , 460-6, (1994)]

Design of novel tyrosine-nitrogen mustard hybrid molecules active against uterine, ovarian and breast cancer cell lines.

2012-04-01

[Steroids 77(5) , 403-12, (2012)]

Probing the binding specificity of C-type lectins in vivo.

2003-01-01

[Meth. Enzymol. 363 , 90-104, (2003)]

More Articles...